sulfatinib
Showing 1 - 5 of 5
Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Sulfatinib
- +3 more
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023
Osteosarcoma Trial in China, Korea, Republic of (Sulfatinib, Etoposide, Isophosphamide)
Not yet recruiting
- Osteosarcoma
- Sulfatinib
- +2 more
-
Beijing, Beijing, China
- +4 more
Oct 19, 2022
Tumor Trial in Beijing (Sulfatinib)
Completed
- Tumor
- Sulfatinib
-
Beijing, ChinaAcademy of Military Medical Affiliated Hopital
Jul 6, 2020
Healthy Trial in Shanghai (Sulfatinib)
Completed
- Healthy
- Sulfatinib
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
May 6, 2020
Neuroendocrine Tumors Trial in China (Sulfatinib)
Completed
- Neuroendocrine Tumors
- Sulfatinib
-
Beijing, Beijing, China
- +6 more
Nov 9, 2018